Cargando…
Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
A recent advance in anti-cancer therapies has been the use of cancer cells to develop vaccines. However, immunization with cancer cell-based vaccines has not resulted in significant long-term therapeutic benefits. A possible reason for this is that while cancer cells provide surface antigens that ar...
Autores principales: | Lokhov, Petr G., Balashova, Elena E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001283/ https://www.ncbi.nlm.nih.gov/pubmed/21151581 |
Ejemplares similares
-
Antigenic Essence: Upgrade of Cellular Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2021) -
SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2017) -
Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2016) -
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
por: Lokhov, Petr G, et al.
Publicado: (2015) -
Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
por: Lokhov, Petr G., et al.
Publicado: (2022)